Neurotech’s ENCELTO: The First FDA-Approved Solution for...

أضاف وظيفة جديدة Health

2025-04-30 04:46:29

Neurotech’s ENCELTO: The First FDA-Approved Solution for MacTel Patients

In a significant achievement for the ophthalmic field, Neurotech’s ENCELTO has earned FDA approval, becoming the first and only approved treatment for Macular Telangiectasia type 2 (MacTel). This groundbreaking therapy offers hope for patients suffering from this rare retinal condition, marking a turning point in the way MacTel is managed. What is Macular Telangiectasia (MacTel)?...

0 التعليقات 0 المشاركات 41 مشاهدة 0 معاينة